• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problems Difficult to Insert (1316); Premature Activation (1484); Activation, Positioning or Separation Problem (2906)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/18/2023
Event Type  malfunction  
Event Description
It was reported that the stent partially deployed.This 7x40, 130 cm eluvia drug-eluting vascular stent system was selected for use in a superficial femoral artery angiogram procedure.Difficulty was experienced during insertion of the stent system at the hub of the 6fr sheath.Then it was noticed that the stent had partially deployed, preventing the system from being introduced into the sheath.The device was removed, and a second stent of the same size was successfully deployed.There were no patient complications.
 
Manufacturer Narrative
Correction to b5: describe event or problem.Correction to h6: device codes.
 
Event Description
It was reported that the stent inadvertently deployed.This 7x40, 130 cm eluvia drug-eluting vascular stent system was selected for use in a superficial femoral artery angiogram procedure.Difficulty was experienced during insertion of the stent system at the hub of the 6fr sheath.Then it was noticed that the stent had inadvertently deployed, preventing the system from being introduced into the sheath.The device was removed, and a second stent of the same size was successfully deployed.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18365850
MDR Text Key331008056
Report Number2124215-2023-72544
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876694
UDI-Public08714729876694
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0031905813
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/18/2023
Initial Date FDA Received12/20/2023
Supplement Dates Manufacturer Received01/19/2024
Supplement Dates FDA Received01/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/13/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-